Inviragen's Series A Round

Inviragen raised a round of funding on October 22, 2009.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's vaccine to protect against dengue fever is in Phase 2 clinical testing. A vaccine designed to …

Articles about Inviragen's Series A Round: